GNMK
GenMark Diagnostics, Inc.

3,295
Loading...
Loading...
GenMark Diagnostics is a molecular diagnostics company focused on developing and commercializing its sensor detection technology. The Companyâ??s electrochemical technology enables the detection of up to 72 distinct biomarkers in a single sample. Its XT-8 System has received 510(k) clearance from the United States Food and Drug Administration (FDA) and is designed to support a range of molecular diagnostic tests with a compact workstation and self-contained, disposable test cartridges. Within 30 minutes of receipt of an amplified deoxyribonucleic acid (DNA) sample, its XT-8 System produces results. The XT-8 System supports up to 24 test cartridges, which can be run independently, and are targeted for hospitals and reference laboratories. The Company is also developing its next-generation platform, the AD-8 System, to integrate DNA amplification with its sensor detection technology to enable technicians to place a minimally prepared patient sample into its test cartridge.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A

Frequently Asked Questions

What is Market Cap of GenMark Diagnostics Inc?
What is the 52-week high for GenMark Diagnostics Inc?
What is the 52-week low for GenMark Diagnostics Inc?
What is GenMark Diagnostics Inc stock price today?
What was GenMark Diagnostics Inc stock price yesterday?
What is the PE ratio of GenMark Diagnostics Inc?
What is the Price-to-Book ratio of GenMark Diagnostics Inc?
What is the 50-day moving average of GenMark Diagnostics Inc?

Latest GNMK News

View
No GNMK news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.